D05.02
Lobular carcinoma in situ of left breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Lobular carcinoma in situ (LCIS) of the breast, particularly when affecting the left breast, is a condition characterized by abnormal cell growth within the lobules — the milk-producing glands of the breast. Although 'carcinoma in situ' suggests that the abnormal cells have not spread beyond their original location, LCIS is a significant indicator that a woman may have an increased risk of developing invasive breast cancer in the future. It is important to understand the nature of LCIS, its underlying causes, how it may present, and the options for monitoring and treatment to manage health effectively.
Causes & Symptoms
Clinical Causes: Genetic factors that increase susceptibility to cell abnormalities in breast tissue Hormonal influences, such as prolonged exposure to estrogen and progesterone Family history of breast cancer or other genetic predispositions Personal history of other benign breast conditions or previous breast biopsies Lifestyle factors including alcohol consumption, obesity, and lack of physical activity
Key Symptoms: Most cases of LCIS are asymptomatic, meaning women do not experience noticeable symptoms Sometimes, an abnormality may be detected during routine mammograms or breast exams In rare cases, it may be discovered when a woman notices a lump or change in the breast tissue, although this is uncommon with LCIS
Diagnostic & Treatment
Diagnosis Path: Diagnosis of LCIS generally involves screening and biopsy procedures, including:
Treatment Protocols: Management of LCIS typically involves careful monitoring and sometimes preventive treatment options, such as:
Clinical Advice & FAQs
Billing Guidance
Is D05.02 a billable ICD-10 code?
Yes, D05.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D05.02?
Clinical documentation must specify the nature of Lobular carcinoma in situ of left breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference